Literature DB >> 163856

Macrophages activated in vitro with lymphocyte mediators kill neoplastic but not normal cells.

W F Piessens, W H Churchill.   

Abstract

Normal guinea pig macrophages incubated for 3 days in vitro with mediator-rich lymphocyte supernatants become cytotoxic for the syngeneic tumors, line 1 hepatoma and MCA-25 fibrosarcoma. Under identical experimental conditions the survival of two normal syngeneic cell types, fibroblasts and kidney cells, was not affected. The activating supernatants were prepared by stimulating sensitized lymphocyte cultures with an antigen unrelated to the target cells. Therefore, this type of macrophage-mediated cytotoxicity appears to be nonspecific but restricted to cells with malignant growth capacities.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 163856

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  44 in total

1.  Immunotherapy and chemoimmunotherapy of malignant disease with BCG and nonviable mycobacterial fractions.

Authors:  M A Schwarz; J U Gutterman; E M Hersh; S P Richman; G M Mavligit
Journal:  World J Surg       Date:  1977-09       Impact factor: 3.352

2.  Modulation of plasminogen activator secretion by activated macrophages: influence of serum factors and correlation with tumoricidal potential.

Authors:  H A Chapman; Z Vavrin; J B Hibbs
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

Review 3.  The role of macrophage activation in chronic inflammation.

Authors:  A C Allison; J Ferluga; H Prydz; H U Schorlemmer
Journal:  Agents Actions       Date:  1978-01

Review 4.  Tumor cells do not arise frequently.

Authors:  W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

5.  Isolation and functional characterization of human intestinal mucosal lymphoid cells.

Authors:  D M Bull; M A Bookman
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

6.  Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. I. Characteristics of SPG-treated macrophages.

Authors:  I Sugawara; K C Lee; M Wong
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

7.  Effects of BCG infection on the susceptibility of mouse macrophages to endotoxin.

Authors:  D L Peavy; R E Baughn; D M Musher; D M Musher
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

8.  Experimental cellular allergic reactions in normal canine and malignant human prostate.

Authors:  M R Robinson; C C Rigby; R C Pugh; L C Vaughan; D C Dumonde
Journal:  Clin Exp Immunol       Date:  1976-10       Impact factor: 4.330

9.  Decrease of three lysosomal enzymes in guinea pig macrophages activated by lymphocyte mediators.

Authors:  H G Remold; A Mednis
Journal:  Inflammation       Date:  1976-03       Impact factor: 4.092

10.  Cytotoxicity of human macrophages for tumor cells. Enhancement by human lymphocyte mediators.

Authors:  D J Cameron; W H Churchill
Journal:  J Clin Invest       Date:  1979-05       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.